Clinical trials in Esslingen Am Neckar – page 2

Extensive studies focusing on non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC), evaluating novel treatment combinations and targeted therapies for various disease stages.

• Advanced and metastatic disease management
• Post-surgical treatment optimization
• Combination therapy approaches

Multiple trials investigating immunotherapy combinations and targeted treatments for improved patient outcomes.

Innovative research targeting hormone receptor-positive and triple-negative breast cancer, exploring new therapeutic strategies and treatment combinations.

• Early-stage disease management
• HER2-negative breast cancer
• Perioperative treatment approaches

Focus on developing personalized treatment strategies and improving survival outcomes.

Groundbreaking studies in chronic lymphocytic leukemia (CLL) and related blood cancers, evaluating novel drug combinations and treatment duration strategies.

• Treatment optimization
• Disease monitoring approaches
• Targeted therapy combinations

Research aimed at improving treatment responses and patient quality of life.

Research focusing on hepatocellular carcinoma and gastric cancer, investigating innovative combination therapies and surgical approaches.

• Advanced disease treatment
• Perioperative therapy
• Immunotherapy applications

Studies evaluating novel treatment strategies for improved patient outcomes.

Clinical trials in ovarian cancer and related conditions, studying maintenance therapies and combination treatments for advanced disease.

• First-line treatment strategies
• Maintenance therapy optimization
• Targeted treatment approaches

Focus on improving survival rates and treatment effectiveness.